Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD)

A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.

A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar.

The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares are surging Thursday after the company announced plans to broaden its drug development activities over the next two years.

Galmed Pharmaceuticals just reported results for the first quarter of 2024.

Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.

Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!

Explore three penny stocks primed for significant growth, backed by Strong Buy ratings from Wall Street. Play it high-risk.

Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.

Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.

GLMD stock results show that Galmed Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

U.S. stocks traded lower toward the end of trading on Tuesday following the release of FOMC minutes. The Dow traded down 0.17% to 35,092.02 while the NASDAQ fell 0.59% to 14,200.33. The S&P 500 also fell, dropping, 0.17% to 4,539.87.

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48.

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday. The Dow traded down 0.25% to 35,062.35 while the NASDAQ fell 0.81% to 14,168.79. The S&P 500 also fell, dropping, 0.34% to 4,531.77.